Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 29, 2013

View Archived Issues

A prognostic peptide-based signature for end-stage renal disease in fetal urinary output

Medimmune to acquire Amplimmune

AiCuris presents a novel class of antibacterial compound with potent activity

An oral multikinase inhibitor shows potent antiangiogenic activity in vivo

Carolus and TAP seek to validate RANTES:Pf-4 as CT-2009 target

Acucela's SEATTLE study reaches half way enrollment

TRPM8 blockade as a potential new treatment strategy for urinary bladder disorders

Licensing and codevelopment agreement for NovaBiotics' first-in-class antifungal peptide

Lee's Pharmaceutical submits CTA to expand the APEX study to China

Orexo updates on OX-51 phase II dose-finding study

Arena Pharmaceuticals completes phase Ib APD-811 trial

FDA accepts for review dabigatran supplemental NDA

U.K.'s NICE does not recommend everolimus use by NHS

Cepheid's Xpert MTB/RIF test categorized by FDA

The University of Virgina presents new sphingosine kinase inhibitors

Novel EGFR inhibitors disclosed by Taiho Pharmaceutical

Scientists at Innate Pharma divulge new MAbs for cancer

Sunovion Pharmaceuticals discloses new antipsychotic agents

FDA extends PDUFA goal date for Xiaflex

Teva decides not to license RX-3117 from Rexahn

Japanese launch for Bonviva injection

Phase II trial planned for CF-102 in hepatocellular carcinoma

Daiichi Sankyo files marketing application for Ranmark in Japan

Grifols and Aradigm close worldwide licensing agreement for inhaled formulations of ciprofloxacin

Europe Commission approves Eylea for visual impairment complications following CRVO

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...
APAC monitors hantavirus as Singapore isolates 2 from cruise ship
BioWorld
Singapore’s Communicable Diseases Agency on May 7 said that it isolated two residents for hantavirus testing after the individuals disembarked from an Atlantic...